Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12979-021-00219-y http://scihub22266oqcxt.onion/10.1186/s12979-021-00219-y 33596958!7886644!33596958     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Immun+Ageing 2021 ; 18 (1): 7 Nephropedia Template TP {{tp|p=33596958|t=2021. Unanticipated efficacy of SARS-CoV-2 vaccination in older adults |pdf=|usr=}}{{33596958}} gab.com Text Unanticipated efficacy of SARS-CoV-2 vaccination in older adults JO: Immun Ageing http://www.kidney.de/pget.php?&tw=1&pmid=33596958 #FOAvip The rapidity with which vaccines against COVID-19 have been developed and tested is unprecedented. As classically the case with randomized clinical trials, many studies excluded older adults. However, given the early realisation that senior citizens were most highly susceptible to COVID, older individuals have been included in licensing trials under these unusual conditions. The recently published results from the Comirnaty Vaccine (BNT162b) trial unexpectedly documented that vaccine efficacy was equally exceptionally high in older and younger adults. These extremely encouraging trial results with a neoantigen vaccine may suggest the beginning of a paradigm shift in our view of the impact of immunosenescence on vaccination against novel infectious diseases. Twit Text FOAVip Unanticipated efficacy of SARS-CoV-2 vaccination in older adults ????Immun Ageing http://www.kidney.de/pget.php?&tw=1&pmid=33596958 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33596958 #FOAvip English Wikipedia <ref>{{Cite pmid|33596958}}</ref> Unanticipated efficacy of SARS-CoV-2 vaccination in older adults #MMPMID33596958 Pawelec G; McElhaney J Immun Ageing 2021[Feb]; 18 (1): 7 PMID33596958show ga The rapidity with which vaccines against COVID-19 have been developed and tested is unprecedented. As classically the case with randomized clinical trials, many studies excluded older adults. However, given the early realisation that senior citizens were most highly susceptible to COVID, older individuals have been included in licensing trials under these unusual conditions. The recently published results from the Comirnaty Vaccine (BNT162b) trial unexpectedly documented that vaccine efficacy was equally exceptionally high in older and younger adults. These extremely encouraging trial results with a neoantigen vaccine may suggest the beginning of a paradigm shift in our view of the impact of immunosenescence on vaccination against novel infectious diseases. äUnanticipated efficacy of SARS-CoV-2 vaccination in older adults (epmc).pdf DeepDyve Pubget Overpricing